Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Limbic encephalitis with caspr2 antibodies is a rare neuroimmunological disorder characterized by the onset of cognitive deficits, psychiatric disturbances (e.g. personality changes), seizures, peripheral nerve hyperexcitability, dysautonomia, neuropathic pain, insomnia and weight loss, in association with detection of caspr2 antibodies in serum or cerebrospinal fluid, with or without underlying malignancies. Other features reported include blepharoclonus, myoclonic status epilepticus, and dyskinesia.
Biomarker and diagnostic research for limbic encephalitis with caspr2 antibodies has been reported in the published literature.
No clinical trials have been registered for limbic encephalitis with caspr2 antibodies.
24 publications have been identified in PubMed for limbic encephalitis with caspr2 antibodies. Research spans Review / Meta-Analysis (33%), Case Report / Case Series (33%), and Diagnostic / Biomarker (17%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 8 | 33% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 11:55 AM UTC
European rare disease database
Patient case studies
8 |
33% |
Testing and diagnosis research | 4 | 17% |
Disease patterns and progression | 4 | 17% |
Masood W (2026). [PMID: 29939664](https://pubmed.ncbi.nlm.nih.gov/29939664/). *Unknown Journal*. [Case Report / Case Series]
Lerch M (2026). [PMID: 41831629](https://pubmed.ncbi.nlm.nih.gov/41831629/). *Autoimmunity reviews*. [Review / Meta-Analysis]
Hänsel M (2025). [PMID: 39891731](https://pubmed.ncbi.nlm.nih.gov/39891731/). *Journal of neurology*. [Diagnostic / Biomarker]
Flegel T (2025). [PMID: 40916498](https://pubmed.ncbi.nlm.nih.gov/40916498/). *Journal of feline medicine and surgery*. [Diagnostic / Biomarker]
Niño Uribe MF (2025). [PMID: 40180343](https://pubmed.ncbi.nlm.nih.gov/40180343/). *BMJ case reports*. [Case Report / Case Series]
Kurkowska-Jastrzębska I (2025). [PMID: 41096807](https://pubmed.ncbi.nlm.nih.gov/41096807/). *International journal of molecular sciences*. [Epidemiology / Natural History]
Terroba-Navajas P (2025). [PMID: 39393351](https://pubmed.ncbi.nlm.nih.gov/39393351/). *Med (New York, N.Y.)*. [Diagnostic / Biomarker]
Alwohaibi A (2025). [PMID: 40519393](https://pubmed.ncbi.nlm.nih.gov/40519393/). *Cureus*. [Case Report / Case Series]
Yu X (2025). [PMID: 40893523](https://pubmed.ncbi.nlm.nih.gov/40893523/). *Quantitative imaging in medicine and surgery*. [Diagnostic / Biomarker]
Brown RL (2025). [PMID: 39985693](https://pubmed.ncbi.nlm.nih.gov/39985693/). *Journal of neurology*. [Review / Meta-Analysis]